verve therapeutics eli lilly - Search News

News

Eli Lilly Buys Verve Therapeutics

Beyond Obesity: Eli Lilly’s Genetic Medicine Bet On Verve Therapeutics

The acquisition aligns with Eli Lilly’s broader diversification strategy beyond its core diabetes and obesity treatment portfolio.

The Wall Street Journal on MSN · 1d

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

Investopedia on MSN · 1d

Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B

Shares of Verve Therapeutics skyrocketed 75% Tuesday morning after Eli Lilly announced that it would acquire the gene-editing startup for about $1.3 billion.

1d

Lilly to Buy Gene-Editing Partner Verve for up to $1.3 Billion in Cardiac Care Push

(Reuters) -Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, aiming ...

1don MSN

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Eli Lilly & Co. aims to offer a one-and-done heart-disease medicine by paying up to $1.3 billion for Verve Therapeutics Inc., ...

1don MSN

This Stock Just Jumped 77% After Eli Lilly Made an Agreed $1.3 Billion Bid

Verve Therapeutics stock jumped after pharmaceutical giant Eli Lilly said it is buying the gene-editing start-up for up to $1 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results